{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:05:25Z","timestamp":1789556725285,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"DOI":"10.7759\/cureus.116341","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:38:46Z","timestamp":1789555126000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Body Mass Index (BMI) in Patients With Beta Thalassemia Major (\u03b2-TM): A Hospital-Based Study"],"prefix":"10.7759","author":[{"given":"Divya","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar","family":"Awadhiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdamba","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.107808","article-title":"Growth and endocrine disorders in thalassemia: the international network on endocrine complications in thalassemia (I-CET) position statement and guidelines","volume":"17","author":"De Sanctis V","year":"2013","unstructured":"De Sanctis V, Soliman AT, Elsedfy H, et al.. Growth and endocrine disorders in thalassemia: the international network on endocrine complications in thalassemia (I-CET) position statement and guidelines. Indian J Endocrinol Metab. 2013, 17:8-18. 10.4103\/2230-8210.107808","journal-title":"Indian J Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1144-5","article-title":"Anemia--still a major health problem in many parts of the world!","volume":"90","author":"Milman N","year":"2011","unstructured":"Milman N. Anemia--still a major health problem in many parts of the world!. Ann Hematol. 2011, 90:369-377. 10.1007\/s00277-010-1144-5","journal-title":"Ann Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.003","article-title":"Changing patterns of thalassemia worldwide","volume":"1054","author":"Vichinsky EP","year":"2005","unstructured":"Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005, 1054:18-24. 10.1196\/annals.1345.003","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)","volume":"54","author":"Vichinsky E","year":"2014","unstructured":"Vichinsky E, Neumayr L, Trimble S, et al.. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014, 54:972-981; quiz 971. 10.1111\/trf.12348","journal-title":"Transfusion"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-012-0114-0","article-title":"Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study","volume":"4","author":"Mohanty D","year":"2013","unstructured":"Mohanty D, Colah RB, Gorakshakar AC, et al.. Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013, 4:33-42. 10.1007\/s12687-012-0114-0","journal-title":"J Community Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0974-5009.126696","article-title":"Thalassemia: an overview","volume":"41","author":"Aggarwal R","year":"2014","unstructured":"Aggarwal R, Prakash A, Aggarwal M. Thalassemia: an overview. J Sci Soc. 2014, 41:3-6. 10.4103\/0974-5009.126696","journal-title":"J Sci Soc"},{"key":"ref7","article-title":"Alpha- and beta-thalassemia: rapid evidence review","volume":"105","author":"Baird DC","year":"2022","unstructured":"Baird DC, Batten SH, Sparks SK. Alpha- and beta-thalassemia: rapid evidence review. Am Fam Physician. 2022, 105:272-280.","journal-title":"Am Fam Physician"},{"key":"ref8","article-title":"Guidelines for the Management of Transfusion-Dependent \u03b2-Thalassaemia (TDT)","author":"Taher AT","year":"2025","unstructured":"Taher AT, Farmakis D, Porter JB, et al.. Guidelines for the Management of Transfusion-Dependent \u03b2-Thalassaemia (TDT). Taher AT, Farmakis D, Porter JB, et al. (ed): Thalassaemia International Federation, Nicosia, Cyprus; 2025."},{"key":"ref9","unstructured":"National Health Mission. Ministry of Health and Family Welfare, Government of India. Guidelines on hemoglobinopathies in India. prevention and control of hemoglobinopathies in India - thalassemias, sickle cell diseases and other variant hemoglobins. (2016). https:\/\/nhm.gov.in\/images\/pdf\/programmes\/RBSK\/Resource_Documents\/Guidelines_on_Hemoglobinopathies_in%20India.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13512","article-title":"Changing patterns in the epidemiology of \u03b2-thalassemia","volume":"105","author":"Kattamis A","year":"2020","unstructured":"Kattamis A, Forni GL, Aydinok Y, Viprakasit V. Changing patterns in the epidemiology of \u03b2-thalassemia. Eur J Haematol. 2020, 105:692-703. 10.1111\/ejh.13512","journal-title":"Eur J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","volume":"2017","author":"Taher AT","year":"2017","unstructured":"Taher AT, Saliba AN. Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017, 2017:265-271. 10.1182\/asheducation-2017.1.265","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/br.2020.1355","article-title":"Novel genetic therapeutic approaches for modulating the severity of \u03b2-thalassemia (review)","volume":"13","author":"Amjad F","year":"2020","unstructured":"Amjad F, Fatima T, Fayyaz T, Khan MA, Qadeer MI. Novel genetic therapeutic approaches for modulating the severity of \u03b2-thalassemia (review). Biomed Rep. 2020, 13:48. 10.3892\/br.2020.1355","journal-title":"Biomed Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_68_18","article-title":"Effectiveness of deferasirox in pediatric thalassemia patients: experience from a tertiary care hospital of Odisha","volume":"52","author":"Panigrahi M","year":"2020","unstructured":"Panigrahi M, Swain TR, Jena RK, Panigrahi A, Debta N. Effectiveness of deferasirox in pediatric thalassemia patients: experience from a tertiary care hospital of Odisha. Indian J Pharmacol. 2020, 52:172-178. 10.4103\/ijp.IJP_68_18","journal-title":"Indian J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.029","article-title":"Cost-utility analysis of four chelation regimens for \u03b2-thalassemia major: a Chinese perspective","volume":"12","author":"Li J","year":"2020","unstructured":"Li J, Wang P, Li X, Wang Q, Zhang J, Lin Y. Cost-utility analysis of four chelation regimens for \u03b2-thalassemia major: a Chinese perspective. Mediterr J Hematol Infect Dis. 2020, 12:e2020029. 10.4084\/MJHID.2020.029","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.730873","article-title":"The future of gene therapy for transfusion-dependent beta-thalassemia: the power of the lentiviral vector for genetically modified hematopoietic stem cells","volume":"12","author":"Rattananon P","year":"2021","unstructured":"Rattananon P, Anurathapan U, Bhukhai K, Hongeng S. The future of gene therapy for transfusion-dependent beta-thalassemia: the power of the lentiviral vector for genetically modified hematopoietic stem cells. Front Pharmacol. 2021, 12:730873. 10.3389\/fphar.2021.730873","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16636","article-title":"Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: a real-world analysis","volume":"61","author":"Tang CH","year":"2021","unstructured":"Tang CH, Furnback W, Wang BCM, et al.. Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: a real-world analysis. Transfusion. 2021, 61:2906-2917. 10.1111\/trf.16636","journal-title":"Transfusion"},{"key":"ref17","unstructured":"Centers for Disease Control and Prevention. Child and teen BMI calculator. (2024). Accessed. August 29, 2026: https:\/\/www.cdc.gov\/bmi\/child-teen-calculator\/index.html."},{"key":"ref18","unstructured":"Centers for Disease Control and Prevention. Child and teen BMI categories. (2024). Accessed. August 29, 2026: https:\/\/www.cdc.gov\/bmi\/child-teen-calculator\/bmi-categories.html."},{"key":"ref19","article-title":"The assessment of nutritional status of children with beta thalassemia major with body mass index","volume":"11","author":"Muhammad AS","year":"2017","unstructured":"Muhammad AS, Muhammad US, Muhammad S. The assessment of nutritional status of children with beta thalassemia major with body mass index. Pak J Med Health Sci. 2017, 11:262-265.","journal-title":"Pak J Med Health Sci"},{"key":"ref20","article-title":"Evaluation some consequences of thalassemia major in splenectomized and non-splenectomized Iraqi patients","volume":"5","author":"Salih KM","year":"2013","unstructured":"Salih KM, and Al-Mosawy WF. Evaluation some consequences of thalassemia major in splenectomized and non-splenectomized Iraqi patients. Int J Pharm Pharmceut Sci. 2013, 5:385-388.","journal-title":"Int J Pharm Pharmceut Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27985","article-title":"Nutritional status in a sample of patients with \u03b2-thalassemia major","volume":"14","author":"Lidoriki I","year":"2022","unstructured":"Lidoriki I, Stavrou G, Schizas D, et al.. Nutritional status in a sample of patients with \u03b2-thalassemia major. Cureus. 2022, 14:e27985. 10.7759\/cureus.27985","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.04.064","article-title":"Relationship between chronic transfusion therapy and body composition in subjects with thalassemia","volume":"157","author":"Fung EB","year":"2010","unstructured":"Fung EB, Xu Y, Kwiatkowski JL, et al.. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia. J Pediatr. 2010, 157:641-647, 647.e1-e2. 10.1016\/j.jpeds.2010.04.064","journal-title":"J Pediatr"},{"key":"ref23","article-title":"The assessment of nutritional status of children with beta thalassemia major with body mass index","volume":"11","author":"Sheikh MA","year":"2017","unstructured":"Sheikh MA, Shakir MU, Shah M. The assessment of nutritional status of children with beta thalassemia major with body mass index. Pak J Med Health Sci. 2017, 11:262-265.","journal-title":"Pak J Med Health Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/09723757.2003.11885858","article-title":"Growth retardation in thalassemia major patients","volume":"3","author":"Saxena A","year":"2017","unstructured":"Saxena A. Growth retardation in thalassemia major patients. Int J Hum Genet. 2017, 3:237-246. 10.1080\/09723757.2003.11885858","journal-title":"Int J Hum Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.19.0066","article-title":"Malnutrition, its attributes, and impact on quality of life: an epidemiological study among \u03b2-thalassemia major children","volume":"42","author":"Biswas B","year":"2021","unstructured":"Biswas B, Naskar NN, Basu K, Dasgupta A, Basu R, Paul B. Malnutrition, its attributes, and impact on quality of life: an epidemiological study among \u03b2-thalassemia major children. Korean J Fam Med. 2021, 42:66-72. 10.4082\/kjfm.19.0066","journal-title":"Korean J Fam Med"},{"key":"ref26","article-title":"Causes of inadequate protein-energy status in thalassemic children","volume":"4","author":"Tanphaichitr VS","year":"1995","unstructured":"Tanphaichitr VS, Visuthi B, Tanphaichitr V. Causes of inadequate protein-energy status in thalassemic children. Asia Pac J Clin Nutr. 1995,  4:133-135.","journal-title":"Asia Pac J Clin Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523005-assessment-of-body-mass-index-bmi-in-patients-with-beta-thalassemia-major--tm-a-hospital-based-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:38:49Z","timestamp":1789555129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523005-assessment-of-body-mass-index-bmi-in-patients-with-beta-thalassemia-major--tm-a-hospital-based-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.116341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}